Hot Pursuit     17-Jan-22
Alembic Pharmaceuticals Ltd drops for fifth straight session
Alembic Pharmaceuticals Ltd is quoting at Rs 798.6, down 0.51% on the day as on 13:24 IST on the NSE. The stock tumbled 25.31% in last one year as compared to a 28.14% rally in NIFTY and a 9.86% spurt in the Nifty Pharma index.

Alembic Pharmaceuticals Ltd fell for a fifth straight session today. The stock is quoting at Rs 798.6, down 0.51% on the day as on 13:24 IST on the NSE. The benchmark NIFTY is up around 0.24% on the day, quoting at 18300.05. The Sensex is at 61293.04, up 0.11%.Alembic Pharmaceuticals Ltd has gained around 4.49% in last one month.Meanwhile, Nifty Pharma index of which Alembic Pharmaceuticals Ltd is a constituent, has increased around 5.44% in last one month and is currently quoting at 13964.15, down 0.45% on the day. The volume in the stock stood at 1.38 lakh shares today, compared to the daily average of 4.09 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 801.5, down 0.46% on the day. Alembic Pharmaceuticals Ltd tumbled 25.31% in last one year as compared to a 28.14% rally in NIFTY and a 9.86% spurt in the Nifty Pharma index.

The PE of the stock is 18.4 based on TTM earnings ending September 21.

Previous News
  Alembic Pharmaceuticals consolidated net profit rises 2.41% in the September 2023 quarter
 ( Results - Announcements 07-Nov-23   15:08 )
  Alembic Pharma Q4 PAT zooms to Rs 153 cr; R&D spend at Rs 136 crore
 ( Hot Pursuit - 06-May-23   14:44 )
  Alembic Pharmaceuticals appoints Head - Technical Operations (Sterile & Oncology)
 ( Corporate News - 16-Sep-24   17:45 )
  Alembic Pharmaceuticals consolidated net profit rises 596.17% in the March 2023 quarter
 ( Results - Announcements 05-May-23   17:32 )
  Alembic Pharmaceuticals Ltd leads losers in 'A' group
 ( Hot Pursuit - 09-Aug-24   15:00 )
  Alembic Pharmaceuticals receives USFDA approval for various products
 ( Corporate News - 09-May-24   09:01 )
  Alembic Pharm gets US FDA approvals for five products in Q1 FY24
 ( Hot Pursuit - 03-Jul-23   09:54 )
  Alembic Pharmaceuticals receives multiple product approvals from USFDA
 ( Corporate News - 03-Jul-23   09:11 )
  Alembic receives USFDA approval for Fesoterodine Fumarate ER Tablets
 ( Corporate News - 06-Jan-23   11:03 )
  Board of Alembic Pharmaceuticals recommends final dividend
 ( Corporate News - 06-May-23   09:20 )
  Alembic Pharma gets USFDA nod for hypertension drug
 ( Hot Pursuit - 30-Mar-23   14:08 )
Other Stories
  Tata Motors total sales drop 11% YoY in Sept’24
  01-Oct-24   15:33
  Vipul Organics hits all-time high after board OKs Rs 25 cr right issue
  01-Oct-24   15:06
  Magellanic Cloud Ltd leads losers in 'A' group
  01-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  01-Oct-24   14:45
  GE Power India rises on bagging order worth Rs 240-cr
  01-Oct-24   14:41
  Volumes jump at Caplin Point Laboratories Ltd counter
  01-Oct-24   14:30
  TVS Motor registers 20% growth in September 2024 sales; Q2 total sales at 12.28 lakh units
  01-Oct-24   14:07
  Oil and Gas shares slide
  01-Oct-24   14:00
  Telecom shares fall
  01-Oct-24   14:00
  Real Estate stocks slide
  01-Oct-24   14:00
Back Top